Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Debunking myths: sickle cell trait, crises, and sudden death.
Journal: Blood advances
Published: April 07, 2025
Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial.
Journal: Open forum infectious diseases
Published: December 17, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 10, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Journal: The New England journal of medicine
Published: July 14, 2021
Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century.
Journal: Human vaccines & immunotherapeutics
Published: May 24, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026